NCT02063360View on ClinicalTrials.gov

DDI Study of BMS-663068 With Etravirine (ETR) and/or Darunavir (DVR) + Ritonavir (RTV)

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

February 1, 2014

Primary Completion Date

May 1, 2014

Study Completion Date

May 13, 2014

Conditions
Infection, Human Immunodeficiency Virus
Interventions
DRUG

BMS-663068

BMS-663068

DRUG

Darunavir (DRV)

Darunavir (DRV)

DRUG

Ritonavir (RTV)

Ritonavir (RTV)

DRUG

Etravirine (ETR)

Etravirine (ETR)

Sponsors

Lead Sponsor

ViiV Healthcare

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

ViiV Healthcare

INDUSTRY